Head to head
Eli Lilly and Co vs Novo-Nordisk A/S
Side-by-side on the measures that matter, with a plain-English read. Full detail: LLY · NVO
LLY
Eli Lilly and Co
1,179.27+0.83%
1-year price shape — +39% over the period
Quant Rating B · 77/100
vs
NVO
Novo-Nordisk A/S
38.64+1.20%
1-year price shape — -31% over the period
Quant Rating E · 11/100
1-year performance, rebased to 100
Novo-Nordisk A/S edges it on the scoreable measures. Novo-Nordisk A/S trades cheapest on trailing earnings; Novo-Nordisk A/S pays the highest dividend yield.
| LLY | NVO | |
|---|---|---|
| Snapshot | ||
| Sector | Drug Manufacturers - General | Drug Manufacturers - General |
| Last price | 1,179.27 | 38.64 |
| Change today | +0.83% | +1.20% |
| 1-year return | +38.7% | -31.0% |
| Market cap | $1.11T | $172.53B |
| 52-week range | 778.93 – 1,292.65 | 34.20 – 61.21 |
| Valuation | ||
| P/E (TTM) | 39.59 | 9.83 |
| P/E percentile, own 5-yr range | 6th | 0th |
| P/B | 32.77 | 5.20 |
| Dividend yield | 0.55% | 4.62% |
| Profitability & growth | ||
| EPS (TTM) | 22.95 | 3.46 |
| Net profit (TTM) | $21.60B | $15.43B |
| Revenue (TTM) | $79.67B | $329.43B |
| Revenue growth (YoY) | +47.7% | +2.1% |
| Gross margin | 83.4% | 80.6% |
| Operating margin | 49.7% | 43.1% |
| Net margin | 33.5% | 35.3% |
| Free cash flow (TTM) | $13.56B | $30.89B |
| Ownership & sentiment | ||
| Institutional ownership | 79.3% | 55.7% |
| Insider activity (12mo) | 37 buy / 13 sell | 0 buy / 0 sell |
| Short interest (% of float) | 0.7% | 0.7% |
| Analyst consensus | 91% buy / 5% hold / 5% sell (22) | 80% hold / 20% sell (5) |
| Analyst price target | $1,383 (+17%) | $43 (+12%) |
| StockVane view | ||
| StockVane Quant Rating | B (77) | E (11) |
| Company | ||
| Employees | 50,000 | 69,505 |
| Founded | 1876 | 1923 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.